Immediate Impact

2 by Nobel laureates 87 standout
Sub-graph 1 of 21

Citing Papers

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
2021 Standout
2 intermediate papers

Works of J. Vinke being referenced

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
1996
A Comparison of 2 Modes of Administration of Recombinant Interleukin-2: Continuous Intravenous Infusion Alone Versus Subcutaneous Administration plus Interferon Alpha in Patients with Advanced Renal Cell Carcinoma.
1993

Author Peers

Author Last Decade Papers Cites
J. Vinke 178 133 55 110 5 283
Grage Tb 192 68 77 90 10 303
Wolfgang Beck 135 225 72 39 5 324
J Hájek 93 224 82 50 3 298
Robert Brownlee 135 154 76 46 7 279
Anne I. van Gessel 78 46 111 134 5 281
C. Norman Coleman 125 46 13 27 7 295
Cinzia Cardalesi 125 58 17 98 8 282
Jane Dancer 132 163 53 70 7 293
G.C. Reid 83 41 81 17 7 288
Hun Jung 160 122 58 9 11 286

All Works

Loading papers...

Rankless by CCL
2026